Indofarma Tbk Revenue vs. Total Debt
| INAF Stock | IDR 126.00 0.00 0.00% |
For Indofarma Tbk profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Indofarma Tbk to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Indofarma Tbk utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Indofarma Tbk's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Indofarma Tbk over time as well as its relative position and ranking within its peers.
Indofarma |
Indofarma Tbk Total Debt vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Indofarma Tbk's current stock value. Our valuation model uses many indicators to compare Indofarma Tbk value to that of its competitors to determine the firm's financial worth. Indofarma Tbk is considered the number one company in revenue category among its peers. It also is considered the number one company in total debt category among its peers making up about 0.14 of Total Debt per Revenue. The ratio of Revenue to Total Debt for Indofarma Tbk is roughly 7.30 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Indofarma Tbk's earnings, one of the primary drivers of an investment's value.Indofarma Revenue vs. Competition
Indofarma Tbk is considered the number one company in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 8.82 Trillion. Indofarma Tbk totals roughly 2.9 Trillion in revenue claiming about 33% of equities under Health Care industry.
Indofarma Total Debt vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Indofarma Tbk |
| = | 2.9 T |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Indofarma Tbk |
| = | 397.52 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Indofarma Total Debt vs Competition
Indofarma Tbk is considered the number one company in total debt category among its peers. Total debt of Health Care industry is currently estimated at about 1.95 Trillion. Indofarma Tbk totals roughly 397.52 Billion in total debt claiming about 20% of equities under Health Care industry.
Indofarma Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Indofarma Tbk. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Indofarma Tbk position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Indofarma Tbk's important profitability drivers and their relationship over time.
Use Indofarma Tbk in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indofarma Tbk position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indofarma Tbk will appreciate offsetting losses from the drop in the long position's value.Indofarma Tbk Pair Trading
Indofarma Tbk Pair Trading Analysis
The ability to find closely correlated positions to Indofarma Tbk could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indofarma Tbk when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indofarma Tbk - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indofarma Tbk to buy it.
The correlation of Indofarma Tbk is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indofarma Tbk moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indofarma Tbk moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indofarma Tbk can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Indofarma Tbk position
In addition to having Indofarma Tbk in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SPAC Thematic Idea Now
SPAC
Entities that are involved in raising capital, merging with and acquiring companies, and investing in private equity through leveraged buyouts. The SPAC theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SPAC Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Indofarma Stock
To fully project Indofarma Tbk's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Indofarma Tbk at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Indofarma Tbk's income statement, its balance sheet, and the statement of cash flows.